Integer Holdings Corporation (ITGR)

Integer Holdings Corp. (ITGR) stock has experienced significant volatility in the past six months. On October 23, 2025, the stock plunged dramatically despite the company reporting third-quarter 2025 earnings that largely met or exceeded analyst expectations, with an 8% increase in sales and a 25% rise in adjusted earnings per share (EPS). The primary drivers for the sell-off were the company's revised full-year 2025 financial guidance, which lowered the sales outlook, and a cautious preliminary outlook for 2026. Additionally, Integer reported an increase in its total debt by $204 million, bringing the total to $1.194 billion. Earlier, on October 10, 2025, the share price was $101.05, a notable decrease from $132.43 on October 14, 2024, representing a 23.70% decline over that period. Furthermore, on September 24, 2025, the stock was down 11% since reporting its Q2 results, trading at $102.97, despite strong performance in revenue and EPS for that quarter.

The medical devices industry, in which Integer Holdings Corp. operates, generally experiences steady demand due to recurring revenue streams and an aging global population. Specifically for ITGR, historical data suggests that October has historically favored a long bias, and a statistically strong window for the stock is anticipated around April 18, 2026.

Integer Holdings Corp. is a global medical device contract development and manufacturing organization (CDMO) that designs, develops, and manufactures components and systems for leading medical technology firms, operating within the Healthcare sector, specifically in the Medical Devices industry. Integer's major products and services cater to the cardiac rhythm management, neuromodulation, and cardio and vascular markets, including components, subassemblies, and finished devices used in various procedures. The company also provides implantable pacemakers and custom medical battery packs and chargers, with brands including Greatbatch Medical and Lake Region Medical.

Integer Holdings Corp. maintains a global presence, operating in the United States, Puerto Rico, Costa Rica, and other international locations. The company has manufacturing facilities strategically located across the United States, Mexico, Uruguay, Ireland, Malaysia, and the Dominican Republic, enabling it to serve medical device companies worldwide.

The provided search results do not offer a direct assessment or specific events that have explicitly impacted Integer Holdings Corp.'s brand reputation in the past year. However, the company's official communications emphasize its role as a strategic partner committed to providing innovative, high-quality medical technologies that enhance patient lives. The recent significant drop in stock price due to revised financial guidance and slower new product adoption could indirectly influence investor perception and confidence.

Integer Holdings Corp. has a diverse ownership structure, with institutional investors holding a substantial portion of the company's stock, ranging from approximately 42.97% to 99.29%. Major institutional shareholders include BlackRock, Inc., Vanguard Group Inc, iShares Core S&P Small-Cap ETF, Invesco Ltd., Dimensional Fund Advisors Lp, State Street Corp, Ameriprise Financial Inc, Viking Global Investors Lp, SMCWX - SMALLCAP WORLD FUND INC Class A, Earnest Partners Llc, Alliancebernstein L.P., and Franklin Resources Inc. Insiders hold approximately 0.83% of the company's stock, while public companies and individual investors account for the remainder.